Chinese Journal of Pharmacovigilance ›› 2011, Vol. 8 ›› Issue (2): 97-99.
Previous Articles Next Articles
XU Wan-kui, YUE Qing-yang, PAN yang
Received:
Revised:
Online:
Published:
Abstract: The manufacturing quality and risk of drug is different, because the manufactring process and environment is different. This paper establishes the integrated risk evaluation system by evaluating 9 risk factors including concentration fluctuations of Omeprazole Enteric-coated Capsules through 32 factories’ products. The purpose of this system is to provide the directed supervision object for government.
Key words: omeprazole enteric-coated capsules, manufacturing quality, risk evaluation
CLC Number:
R954
XU Wan-kui, YUE Qing-yang, PAN yang. The Risk Assessment System for Omeprazole Enteric-coated Capsules Manufacturing[J]. Chinese Journal of Pharmacovigilance, 2011, 8(2): 97-99.
0 / Recommend
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgywjj.com/EN/
https://www.zgywjj.com/EN/Y2011/V8/I2/97